Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients …
… Gervitz is an employee of UCB Pharma and owns shares of UCB Pharma. Prof. Furst has
received grant/research support from Abbott, Actelion, Amgen, BMS, Centocor, Genentech, …
received grant/research support from Abbott, Actelion, Amgen, BMS, Centocor, Genentech, …
Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo
LM Gervitz, LO Lutherer, DG Davies… - American Journal …, 2001 - journals.physiology.org
The present study was designed to investigate the role of adenosine in the hypoxic
depression of synaptic transmission in rat hippocampus. An in vivo model of hypoxic synaptic …
depression of synaptic transmission in rat hippocampus. An in vivo model of hypoxic synaptic …
Systemic hypoxia and the depression of synaptic transmission in rat hippocampus after carotid artery occlusion
JC Fowler, LM Gervitz, ME Hamilton… - The Journal of …, 2003 - Wiley Online Library
The relationship between step reductions in inspired oxygen and the amplitude of evoked field
excitatory postsynaptic potentials (fEPSPs) recorded from hippocampal CA1 neurons was …
excitatory postsynaptic potentials (fEPSPs) recorded from hippocampal CA1 neurons was …
Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo
LM Gervitz, D Nalbant, SC Williams, JC Fowler - Neuroscience letters, 2002 - Elsevier
Adenosine is considered an endogenous neuroprotective metabolite that through activation
of the A 1 receptor results in reduction of neuronal damage following cerebral ischemia. …
of the A 1 receptor results in reduction of neuronal damage following cerebral ischemia. …
The effect of acute hypoxemia and hypotension on adenosine-mediated depression of evoked hippocampal synaptic transmission
LM Gervitz, DG Davies, K Omidvar, JC Fowler - Experimental neurology, 2003 - Elsevier
The present study was designed to investigate the relative contributions of arterial P O 2 ,
local cerebral blood flow, and oxygen delivery to the adenosine A 1 receptor-mediated …
local cerebral blood flow, and oxygen delivery to the adenosine A 1 receptor-mediated …
Lack of central effects of peripherally administered adenosine A1 agonists on synaptic transmission in the rat hippocampus
LM Gervitz, LO Lutherer, ME Hamilton, JC Fowler - Brain research, 2002 - Elsevier
Peripheral administration of adenosine A 1 receptor selective agonists is generally thought
to protect the hippocampus against ischemic damage via central actions. We examined the …
to protect the hippocampus against ischemic damage via central actions. We examined the …
SAT0137 Patients (pts) switched to sarilumab from adalimumab achieve clinically important improvements in ra disease activity: results from monarch trial open-label …
…, A Rubbert-Roth, H van Hoogstraten, LM Gervitz… - 2019 - ard.bmj.com
Background: In MONARCH (NCT02332590), sarilumab monotherapy (200 mg subcutaneously
[SC] every 2 weeks [q2w]) demonstrated superiority to adalimumab monotherapy (40 mg …
[SC] every 2 weeks [q2w]) demonstrated superiority to adalimumab monotherapy (40 mg …
[BOOK][B] Adenosine and blood flow regulatory mechanisms in hippocampal ischemia
LM Gervitz - 2002 - search.proquest.com
INFORMATION TO USERS Page 1 INFORMATION TO USERS This manuscript has been
reproduced from the microfilm master. UMI films the text directly from the original or copy …
reproduced from the microfilm master. UMI films the text directly from the original or copy …
[CITATION][C] Lutherer LO, Davies DG, Pirch JH, and Fowler JC
LM Gervitz - Adenosine induces initial hypoxic-ischemic depression …, 2001
[CITATION][C] … Lack of central effects of peripherally administered adenosine A agonists on synaptic transmission in the rat hippocampus LM Gervitz, LO Lutherer, ME …
DG Whyte, AK Johnson, M Sakata, H Sei, K Toida… - 2002